Thoracic aortic disease — including aneurysms, dissections, traumatic injuries, and penetrating ulcers — has historically required major open surgical repair through thoracotomy or sternotomy with hypothermic circulatory arrest. Thoracic endovascular aortic repair (TEVAR) introduced a catheter-based alternative in the early 2000s, deploying a covered stent graft within the diseased aorta through the femoral artery. TEVAR has rapidly become the preferred approach for descending thoracic aortic pathology in many situations. However, the choice between TEVAR and open repair is not straightforward. Anatomy, pathology location, patient age, connective tissue disorders, and the need for arch or root involvement all influence the decision. TEVAR is ideal for the descending thoracic aorta but cannot address the ascending aorta or aortic root — open surgery remains mandatory for these regions. Even in the descending aorta, long-term durability concerns, endoleak rates, and the need for reintervention distinguish TEVAR from the proven durability of open repair. This decision requires specialized expertise in both open aortic surgery and endovascular techniques — the hallmark of a comprehensive aortic program.
TEVAR deploys a covered stent graft within the thoracic aorta via catheter access through the femoral artery. The graft excludes the diseased segment from blood flow, allowing it to thrombose and remodel over time. The procedure is performed under fluoroscopic guidance, typically with general or regional anesthesia. Modern devices offer improved conformability and branch/fenestrated options for arch and visceral involvement.
Open thoracic aortic repair involves replacing the diseased aortic segment with a prosthetic Dacron graft through a thoracotomy (descending aorta) or sternotomy (ascending/arch). For ascending and arch repairs, deep hypothermic circulatory arrest (DHCA) or moderate hypothermia with antegrade cerebral perfusion is used to protect the brain during periods of circulatory interruption. It remains the only option for ascending aortic and aortic root pathology.
The 2022 ACC/AHA Guideline for Aortic Disease recommends TEVAR for descending thoracic aneurysms meeting size criteria (>5.5 cm or rapid growth) with favorable anatomy (Class I). Open repair is recommended for ascending aortic aneurysms >5.5 cm (Class I), or >5.0 cm in the presence of risk factors. For acute Type A dissection, emergency open surgical repair is mandatory (Class I). For complicated Type B dissection, TEVAR is recommended (Class I). Management should occur at experienced aortic centers.
Aortic disease management requires a specialized team — often called an "Aortic Team" — comprising cardiac surgeons with open aortic expertise, endovascular specialists, and imaging experts. The decision between TEVAR and open repair depends on precise anatomical assessment (landing zones, branch vessel involvement, connective tissue status), pathology type, and patient risk profile. WhiteGloveMD provides this multidisciplinary aortic evaluation, helping patients understand whether endovascular or open repair offers the best risk-benefit profile.
TEVAR has transformed the treatment of descending thoracic aortic disease, offering lower perioperative mortality and faster recovery. However, open repair remains essential for ascending aortic disease, connective tissue disorders, and complex arch pathology. Long-term durability and surveillance requirements of TEVAR must be weighed against the proven permanence of open repair. The decision should be made at an experienced aortic center capable of both approaches.
No. TEVAR is limited to the descending thoracic aorta with adequate healthy landing zones. Ascending aortic aneurysms, arch aneurysms without suitable anatomy, and patients with connective tissue disorders generally require open surgical repair.
An endoleak is persistent blood flow around or through a stent graft, pressurizing the aneurysm sac. Type I (attachment site leak) and Type III (graft defect) require reintervention. Type II (branch vessel backflow) is often observed. Endoleaks are the primary reason TEVAR patients need lifelong CT surveillance.
Type A dissection (involving the ascending aorta) requires emergency open surgery — this is one of the true surgical emergencies in medicine. Type B dissection (limited to the descending aorta) is initially managed with blood pressure control and pain management, with TEVAR reserved for complications (malperfusion, rupture, rapid expansion).
Our Heart Team evaluates your specific anatomy, risk factors, and goals to recommend the best approach. 48-hour turnaround.